Shiseido Unveils Strategy For Returning Company To Growth In 2013
This article was originally published in The Rose Sheet
Executive Summary
Shiseido has strategic initiatives planned for its domestic and Chinese businesses and Bare Escentuals in the U.S. following a disappointing fiscal 2012 in which the Toyko-based firm recorded a net loss of $148 million.
You may also be interested in...
Newhall Laboratories Works To Refresh Venerable Personal-Care Brands
La Bella, L.A. Looks and Soft & Dri have new websites and new marketing strategies behind them as Newhall Laboratories endeavors to rejuvenate personal-care brands it’s acquired over the past year and a half.
GE Healthcare Partners With China’s BGI For Stem Cell Drug Discovery
The partners will examine the underlying genetic variation between ethnically diverse human stem cells, which can give scientists a more precise picture of the effect of a certain therapy compared to animal models.
Hepatitis A Vaccinations On The Rise In Asia With Travelers From Developed Nations Most At Risk
Hepatitis A is considered a high risk in Asia, but the infection is not known as a public health priority since most people develop immunity against HAV during early childhood when infections are usually asymptomatic.